A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive Mutation
Clinical trial NCT03420079 · UNKNOWN
Trial details
- NCT number
- NCT03420079
- Sponsor
- Ahon Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2020-12-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.